Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis

Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity amon...

Full description

Saved in:
Bibliographic Details
Published inNutrition & metabolism Vol. 14; no. 1; p. 60
Main Authors Zhu, Xiangyun, Wu, Chunhua, Qiu, Shanhu, Yuan, Xuelu, Li, Ling
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 22.09.2017
BioMed Central
BMC
Subjects
Analysis
Bias
blood glucose
Blood pressure
Cholesterol
Clinical trials
computer software
Diabetes
Diabetes mellitus
diastolic blood pressure
Dosage and administration
Drug therapy
drugs
Fasting
Glucose
glycemic control
glycohemoglobin
Glycosylated hemoglobin
Hemoglobin
high density lipoprotein cholesterol
Homeostasis
Insulin
Insulin resistance
Kinases
Laboratory testing
low density lipoprotein cholesterol
Meta-analysis
noninsulin-dependent diabetes mellitus
patients
Quality control
randomized clinical trials
Resveratrol
Review
Statistical analysis
Supplements
Systematic review
systolic blood pressure
Type 2 diabetes
Type 2 diabetes
Resveratrol
Meta-analysis
Online AccessGet full text

Cover

Abstract Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
AbstractList Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, p < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus [greater than or equai to] 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, p < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus [greater than or equai to] 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM. Keywords: Resveratrol, Type 2 diabetes, Meta-analysis
Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
Abstract Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( −0.29 mmol/l, 95% CI: −0.51, −0.06, p < 0.01) and insulin levels (−0.64 U/mL, 95% CI: −0.95, −0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( −0.29 mmol/l, 95% CI: −0.51, −0.06, p < 0.01) and insulin levels (−0.64 U/mL, 95% CI: −0.95, −0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, p < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( -0.29 mmol/l, 95% CI: -0.51, -0.06, p < 0.01) and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus (T2DM), the reported results are inconsistent. Thus, we aimed to assess the effects of resveratrol on glycemic control and insulin sensitivity among patients with T2DM. We searched for relevant articles published until June 2017 on PubMed-Medline, Embase, Cochrane Library, and Web of Science. Randomized controlled trials in T2DM patients administered with resveratrol as intervention were included. After study selection, quality assessment and data extraction were performed independently by two authors, and STATA and RevMan software were used for statistical analysis. Nine randomized controlled trials involving 283 participants were included. Meta-analysis showed that resveratrol significantly improved the fasting plasma glucose ( −0.29 mmol/l, 95% CI: −0.51, −0.06, p < 0.01) and insulin levels (−0.64 U/mL, 95% CI: −0.95, −0.32, p < 0.0001). The drug also reduced homeostasis model assessment of insulin resistance (HOMA-IR) index, systolic blood pressure, and diastolic blood pressure among participants with T2DM. The changes in hemoglobin A1c (HbA1c), low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were negligible. Subgroup analysis comparing the resveratrol supplementation doses of < 100 mg/d versus ≥ 100 mg/d revealed a significant difference in fasting plasma glucose. In particular, the latter dose presented more favorable results. This meta-analysis provides evidence that supplementation of resveratrol may benefit management of T2DM.
ArticleNumber 60
Audience Academic
Author Yuan, Xuelu
Wu, Chunhua
Li, Ling
Zhu, Xiangyun
Qiu, Shanhu
Author_xml – sequence: 1
  givenname: Xiangyun
  surname: Zhu
  fullname: Zhu, Xiangyun
– sequence: 2
  givenname: Chunhua
  surname: Wu
  fullname: Wu, Chunhua
– sequence: 3
  givenname: Shanhu
  surname: Qiu
  fullname: Qiu, Shanhu
– sequence: 4
  givenname: Xuelu
  surname: Yuan
  fullname: Yuan, Xuelu
– sequence: 5
  givenname: Ling
  surname: Li
  fullname: Li, Ling
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29018489$$D View this record in MEDLINE/PubMed
BookMark eNqFU8tu1DAUjVARfcAHsEGW2MAixc7LNgukqiowUiUkHmvr2rmeepSJh9iZMv0BfhtnppROhUCRHOf6nBP7-Nzj7KD3PWbZc0ZPGRPNm8AKKZqcMp7TIg03j7Ijxqsy55TXB_fmh9lxCAtKy7KS9El2WEjKRCXkUfbzwlo0MRBvyYBhjQPEwXfE92TejcYHJMb32xL0LXF9GDvXk4B9cNGtXdyQ6XPUi63KtYtXJG5WSArSOtAYMbwlYRMiLiE6k_6xdni91VpihBx66DbBhafZYwtdwGe375Ps2_uLr-cf88tPH2bnZ5e5aQoe88rawqJsKBQooTRMQkWbBngjeGO14FozQLTppIXUVGhTCM0tci3bum5keZLNdrqth4VaDW4Jw0Z5cGpb8MNcwZA22qFCMFIzW4mWN5UUAKIWVCe3KlrzSuik9W6ntRr1EluDySfo9kT3V3p3peZ-reqG0VLWSeDVrcDgv48Yolq6YLDroEc_BlXQupTp-mT5XyiTdbpSJotJ9eUD6MKPQ_J5QlW8Lqmsqz-oOaSzut76tEUziaqzmnLGWMF5Qp3-BZWeFpcuBQOtS_U9wus9whQe_BHnMIagZl8-72Nf3Pfvzrjf6UwAtgOYwYcwoL2DMKqmDlC7DlCpA9TUAeomcfgDjnExRW8KMbjuH8xfvw8LGg
CitedBy_id crossref_primary_10_3390_ijms241411640
crossref_primary_10_3390_molecules27165232
crossref_primary_10_1186_s12872_022_02637_2
crossref_primary_10_1007_s13205_021_03078_y
crossref_primary_10_1080_10717544_2023_2174206
crossref_primary_10_3390_ph14080806
crossref_primary_10_3390_ijms19092584
crossref_primary_10_3390_nu11102381
crossref_primary_10_1002_ptr_6487
crossref_primary_10_1152_ajpcell_00141_2019
crossref_primary_10_1002_14651858_CD011919_pub2
crossref_primary_10_1016_j_phrs_2019_04_020
crossref_primary_10_1016_j_lfs_2020_117727
crossref_primary_10_1042_BSR20171741
crossref_primary_10_3390_nu12051505
crossref_primary_10_1016_j_numecd_2019_11_015
crossref_primary_10_3389_fnut_2022_854255
crossref_primary_10_1155_2021_5644171
crossref_primary_10_1186_s43088_022_00269_1
crossref_primary_10_1016_j_jdent_2024_104876
crossref_primary_10_1111_eea_12981
crossref_primary_10_2174_1381612825666190705191000
crossref_primary_10_1039_D3FO04761J
crossref_primary_10_1111_bph_15895
crossref_primary_10_1080_10408398_2021_1875980
crossref_primary_10_1093_ajcn_nqab250
crossref_primary_10_1007_s00439_023_02616_3
crossref_primary_10_3390_jcm9020313
crossref_primary_10_1021_acs_jafc_9b00455
crossref_primary_10_3390_biomedicines10123045
crossref_primary_10_3390_nu14081633
crossref_primary_10_1080_00016357_2020_1797159
crossref_primary_10_3390_foods9050544
crossref_primary_10_3389_fpls_2023_1133062
crossref_primary_10_4239_wjd_v14_i2_76
crossref_primary_10_32604_biocell_2023_031043
crossref_primary_10_15406_jcpcr_2018_09_00356
crossref_primary_10_1111_iwj_13601
crossref_primary_10_3390_molecules25184340
crossref_primary_10_3390_antiox12061212
crossref_primary_10_3390_nu12030828
crossref_primary_10_15275_rusomj_2020_0411
crossref_primary_10_1002_jcp_27506
crossref_primary_10_1017_S2040174422000332
crossref_primary_10_3390_antiox9060469
crossref_primary_10_1177_1934578X251323393
crossref_primary_10_3390_plants10010090
crossref_primary_10_4239_wjd_v14_i6_808
crossref_primary_10_1016_j_ctim_2022_102819
crossref_primary_10_1016_j_ctim_2019_102251
crossref_primary_10_1002_oby_22348
crossref_primary_10_1016_j_archoralbio_2024_106016
crossref_primary_10_1016_j_abb_2024_110283
crossref_primary_10_1016_j_plipres_2019_101006
crossref_primary_10_3390_molecules25235645
crossref_primary_10_18016_ksutarimdoga_vi_1518465
crossref_primary_10_3390_molecules25092224
crossref_primary_10_1016_j_medcle_2021_06_027
crossref_primary_10_3390_antiox13050510
crossref_primary_10_1016_j_biopha_2018_03_050
crossref_primary_10_3390_macromol4040048
crossref_primary_10_1038_s41598_023_50084_6
crossref_primary_10_3390_nu14142870
crossref_primary_10_3389_fimmu_2018_02992
crossref_primary_10_1111_jdi_13303
crossref_primary_10_3390_cells9081882
crossref_primary_10_1016_j_medcli_2021_06_028
crossref_primary_10_1016_j_clnu_2021_02_004
crossref_primary_10_1016_j_heliyon_2022_e12698
crossref_primary_10_1186_s12906_024_04509_y
crossref_primary_10_3389_fphar_2022_863707
crossref_primary_10_1038_s41430_018_0253_4
crossref_primary_10_3390_molecules28145525
crossref_primary_10_1016_j_clnu_2020_08_025
crossref_primary_10_2174_1573399815666190906151319
crossref_primary_10_3390_endocrines5020016
crossref_primary_10_1007_s11064_022_03787_7
crossref_primary_10_3390_antiox11061085
crossref_primary_10_3390_nu14010215
crossref_primary_10_3389_fcvm_2020_585309
crossref_primary_10_3390_nu10111651
crossref_primary_10_3390_nu12103135
crossref_primary_10_1155_2018_2150218
crossref_primary_10_3390_nu12010161
crossref_primary_10_3892_etm_2019_8372
crossref_primary_10_1007_s43032_021_00653_9
crossref_primary_10_3390_cimb44050147
crossref_primary_10_1016_j_biopha_2019_109767
crossref_primary_10_1016_j_jsps_2019_08_006
crossref_primary_10_3390_antiox10010069
crossref_primary_10_3390_nu10091160
crossref_primary_10_1007_s11101_024_10047_9
crossref_primary_10_1007_s11064_020_02997_1
crossref_primary_10_3746_pnf_2022_27_3_257
crossref_primary_10_1016_j_nutres_2023_03_002
crossref_primary_10_3390_ijms20071523
crossref_primary_10_1155_2022_5649156
crossref_primary_10_3390_ijms22094792
crossref_primary_10_1016_j_phrs_2021_105725
crossref_primary_10_1007_s10787_019_00663_9
crossref_primary_10_31793_1680_1466_2020_25_1_76
crossref_primary_10_1080_10408398_2017_1422480
crossref_primary_10_3389_fphys_2019_00899
crossref_primary_10_3390_nu13093095
crossref_primary_10_1016_j_repbio_2019_09_006
crossref_primary_10_12996_gmj_2024_4232
crossref_primary_10_2174_1567205016666190801153751
crossref_primary_10_1007_s11845_020_02441_x
crossref_primary_10_1080_10717544_2019_1704944
crossref_primary_10_1039_D0FO02387F
crossref_primary_10_3390_nu12030739
crossref_primary_10_3390_nu12041066
crossref_primary_10_1007_s40290_019_00289_w
crossref_primary_10_1155_2023_6385767
crossref_primary_10_1016_j_phyplu_2022_100280
crossref_primary_10_1016_j_phrs_2017_12_033
crossref_primary_10_1017_S0007114521003330
Cites_doi 10.1016/j.diabres.2013.11.002
10.1155/2014/816307
10.1111/dom.12760
10.1016/j.dld.2014.11.015
10.1016/S1734-1140(11)70635-1
10.1016/j.jhep.2008.08.012
10.1123/ijsnem.2013-0045
10.1016/j.diabres.2010.01.026
10.1186/1475-2891-6-30
10.1017/S0007114511000316
10.2337/dc13-2114
10.1155/2013/851267
10.4103/1735-1995.168405
10.1089/met.2014.0082
10.1016/j.phrs.2016.08.010
10.1016/j.ijsu.2010.02.007
10.1136/bmj.315.7109.629
10.1371/journal.pone.0050412
10.1210/en.2009-0528
10.1002/mnfr.201400173
10.1371/journal.pone.0034289
10.3945/ajcn.115.117440
10.1016/S2213-8587(14)70219-0
10.2337/dc16-0499
10.1016/j.phrs.2013.03.011
10.1007/s12020-016-1212-2
10.1002/jrsm.12
10.1016/j.numecd.2016.03.003
10.1111/dom.12778
10.1016/j.nutres.2012.06.003
10.1139/bcb-2014-0136
10.2337/db09-0482
10.1155/2016/9737483
10.1016/j.jnutbio.2011.04.007
10.1017/S0007114515002433
10.1002/mnfr.201400933
10.4238/2011.November.29.7
10.3945/ajcn.113.082024
10.1002/ptr.5737
ContentType Journal Article
Copyright COPYRIGHT 2017 BioMed Central Ltd.
Copyright BioMed Central 2017
The Author(s). 2017
Copyright_xml – notice: COPYRIGHT 2017 BioMed Central Ltd.
– notice: Copyright BioMed Central 2017
– notice: The Author(s). 2017
DBID AAYXX
CITATION
NPM
ISR
3V.
7QP
7RV
7TS
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
KB0
M0S
M1P
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
DOA
DOI 10.1186/s12986-017-0217-z
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Physical Education Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
Physical Education Index
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList

PubMed


Publicly Available Content Database
MEDLINE - Academic

AGRICOLA
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
EISSN 1743-7075
EndPage 60
ExternalDocumentID oai_doaj_org_article_eac9b1f48d76498aa8580bfec405748b
PMC5610395
A507111277
29018489
10_1186_s12986_017_0217_z
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: 81570739
GroupedDBID ---
04C
0R~
123
29N
2WC
53G
5VS
7RV
7X7
88E
8FI
8FJ
8G5
A8Z
AAFWJ
AAHBH
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BMSDO
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EIHBH
EJD
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HH5
HMCUK
HYE
IAO
ICU
IHR
ISR
ITC
KQ8
M1P
M2O
M48
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SCM
SOJ
SV3
TUS
UKHRP
WOQ
WOW
XSB
2VQ
4.4
AHSBF
C1A
EX3
IPNFZ
NPM
PJZUB
PPXIY
RIG
PMFND
3V.
7QP
7TS
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c627t-4ff2fe960a2e9a3c19a4066a76876fb87bb1aeef03329b08bc28b7fe7b9d55693
IEDL.DBID M48
ISSN 1743-7075
IngestDate Wed Aug 27 01:28:23 EDT 2025
Thu Aug 21 14:07:14 EDT 2025
Mon Jul 21 10:21:59 EDT 2025
Thu Jul 10 23:15:10 EDT 2025
Fri Jul 25 21:48:21 EDT 2025
Tue Jun 17 21:47:32 EDT 2025
Tue Jun 10 20:21:51 EDT 2025
Fri Jun 27 04:43:10 EDT 2025
Mon Jul 21 06:01:32 EDT 2025
Thu Apr 24 23:07:04 EDT 2025
Tue Jul 01 02:17:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Type 2 diabetes
Resveratrol
Meta-analysis
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c627t-4ff2fe960a2e9a3c19a4066a76876fb87bb1aeef03329b08bc28b7fe7b9d55693
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12986-017-0217-z
PMID 29018489
PQID 1947530954
PQPubID 55142
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_eac9b1f48d76498aa8580bfec405748b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5610395
proquest_miscellaneous_2053907593
proquest_miscellaneous_1950181925
proquest_journals_1947530954
gale_infotracmisc_A507111277
gale_infotracacademiconefile_A507111277
gale_incontextgauss_ISR_A507111277
pubmed_primary_29018489
crossref_primary_10_1186_s12986_017_0217_z
crossref_citationtrail_10_1186_s12986_017_0217_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-22
PublicationDateYYYYMMDD 2017-09-22
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-22
  day: 22
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Nutrition & metabolism
PublicationTitleAlternate Nutr Metab (Lond)
PublicationYear 2017
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References F Faghihzadeh (217_CR33) 2015; 114
J Marchal (217_CR35) 2012; 7
YK Bashmakov (217_CR26) 2014; 2014
SS Thazhath (217_CR17) 2016; 103
M Egger (217_CR20) 1997; 315
K Liu (217_CR32) 2014; 99
P Brasnyo (217_CR15) 2011; 106
HA Hausenblas (217_CR18) 2015; 59
MI Patel (217_CR13) 2011; 63
S Timmers (217_CR29) 2016; 39
SC Bain (217_CR5) 2016; 18
OR Oyenihi (217_CR6) 2016; 2016
JH Um (217_CR12) 2010; 59
217_CR31
D Moher (217_CR19) 2010; 8
CL Martin (217_CR3) 2014; 37
L Chen (217_CR36) 2017; 55
G Block (217_CR22) 2007; 6
L Guariguata (217_CR2) 2014; 103
J Tome-Carneiro (217_CR30) 2013; 72
YE Lee (217_CR9) 2012; 7
S Bo (217_CR16) 2016; 111
M Mendez-del Villar (217_CR7) 2014; 12
AS Yar (217_CR10) 2011; 10
RHX Wong (217_CR23) 2016; 26
F Faghihzadeh (217_CR34) 2015; 20
M Azorin-Ortuno (217_CR38) 2012; 23
A Gonzalez-Rodriguez (217_CR8) 2015; 59
N Jeffery (217_CR1) 2016; 18
JK Bhatt (217_CR14) 2012; 32
A Movahed (217_CR28) 2013; 2013
S Chen (217_CR24) 2015; 47
J Ahn (217_CR39) 2008; 49
P Zhang (217_CR4) 2010; 87
M Borenstein (217_CR21) 2010; 1
AD Shah (217_CR37) 2015; 3
B Wicklow (217_CR25) 2015; 93
KP Goh (217_CR27) 2014; 24
G Ramadori (217_CR11) 2009; 150
28050570 - J Diabetes Res. 2016;2016:9737483
21852083 - J Nutr Biochem. 2012 Jul;23(7):829-37
17958896 - Nutr J. 2007 Oct 24;6:30
24630390 - Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
9310563 - BMJ. 1997 Sep 13;315(7109):629-34
20171303 - Int J Surg. 2010;8(5):336-41
23226280 - PLoS One. 2012;7(11):e50412
22901562 - Nutr Res. 2012 Jul;32(7):537-41
24073011 - Evid Based Complement Alternat Med. 2013;2013:851267
27105868 - Nutr Metab Cardiovasc Dis. 2016 May;26(5):393-9
27550203 - Diabetes Obes Metab. 2016 Dec;18(12 ):1167-1175
18930334 - J Hepatol. 2008 Dec;49(6):1019-28
25466521 - Lancet Diabetes Endocrinol. 2015 Feb;3(2):105-13
24695890 - Am J Clin Nutr. 2014 Jun;99(6):1510-9
25137036 - Metab Syndr Relat Disord. 2014 Dec;12(10):497-501
28070709 - Endocrine. 2017 Mar;55(3):773-785
24356595 - Diabetes Care. 2014;37(1):31-8
20171754 - Diabetes Res Clin Pract. 2010 Mar;87(3):293-301
27520400 - Pharmacol Res. 2016 Sep;111:896-905
26664429 - J Res Med Sci. 2015 Aug;20(8):797-810
24701359 - ISRN Endocrinol. 2014 Feb 20;2014:816307
25577300 - Dig Liver Dis. 2015 Mar;47(3):226-32
23557933 - Pharmacol Res. 2013 Jun;72:69-82
23918588 - Int J Sport Nutr Exerc Metab. 2014 Feb;24(1):2-13
27852684 - Diabetes Care. 2016 Dec;39(12 ):2211-2217
25808216 - Mol Nutr Food Res. 2015 Aug;59(8):1431-42
26061376 - Res Synth Methods. 2010 Apr;1(2):97-111
27807887 - Phytother Res. 2017 Jan;31(1):108-114
21385509 - Br J Nutr. 2011 Aug;106(3):383-9
22179968 - Genet Mol Res. 2011 Nov 29;10(4):2962-75
19934007 - Diabetes. 2010 Mar;59(3):554-63
27491724 - Diabetes Obes Metab. 2016 Dec;18(12 ):1157-1166
22180358 - Pharmacol Rep. 2011;63(5):1162-8
25138371 - Mol Nutr Food Res. 2015 Jan;59(1):147-59
26305052 - Biochem Cell Biol. 2015 Oct;93(5):522-30
26607942 - Am J Clin Nutr. 2016 Jan;103(1):66-70
26234526 - Br J Nutr. 2015 Sep 14;114(5):796-803
22479589 - PLoS One. 2012;7(3):e34289
19819963 - Endocrinology. 2009 Dec;150(12):5326-33
References_xml – volume: 103
  start-page: 137
  year: 2014
  ident: 217_CR2
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2013.11.002
– volume: 2014
  start-page: 816307
  year: 2014
  ident: 217_CR26
  publication-title: ISRN Endocrinology
  doi: 10.1155/2014/816307
– volume: 18
  start-page: 1157
  year: 2016
  ident: 217_CR5
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12760
– volume: 47
  start-page: 226
  year: 2015
  ident: 217_CR24
  publication-title: Dig Liver Dis
  doi: 10.1016/j.dld.2014.11.015
– volume: 63
  start-page: 1162
  year: 2011
  ident: 217_CR13
  publication-title: Pharmacol Rep
  doi: 10.1016/S1734-1140(11)70635-1
– volume: 49
  start-page: 1019
  year: 2008
  ident: 217_CR39
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2008.08.012
– volume: 24
  start-page: 2
  year: 2014
  ident: 217_CR27
  publication-title: Int J Sport Nutr Exerc Metab
  doi: 10.1123/ijsnem.2013-0045
– volume: 87
  start-page: 293
  year: 2010
  ident: 217_CR4
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2010.01.026
– volume: 6
  start-page: 30
  year: 2007
  ident: 217_CR22
  publication-title: Nutr J
  doi: 10.1186/1475-2891-6-30
– volume: 106
  start-page: 383
  year: 2011
  ident: 217_CR15
  publication-title: Br J Nutr
  doi: 10.1017/S0007114511000316
– volume: 37
  start-page: 31
  year: 2014
  ident: 217_CR3
  publication-title: Diabetes Care
  doi: 10.2337/dc13-2114
– volume: 2013
  start-page: 851267
  year: 2013
  ident: 217_CR28
  publication-title: Evidence-based Complementary and Alternative Medicine
  doi: 10.1155/2013/851267
– volume: 20
  start-page: 797
  issue: 8
  year: 2015
  ident: 217_CR34
  publication-title: J Res Med Sci
  doi: 10.4103/1735-1995.168405
– volume: 12
  start-page: 497
  year: 2014
  ident: 217_CR7
  publication-title: Metab Syndr Relat Disord
  doi: 10.1089/met.2014.0082
– volume: 111
  start-page: 896
  year: 2016
  ident: 217_CR16
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2016.08.010
– volume: 8
  start-page: 336
  year: 2010
  ident: 217_CR19
  publication-title: Int J Surg
  doi: 10.1016/j.ijsu.2010.02.007
– volume: 315
  start-page: 629
  year: 1997
  ident: 217_CR20
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 7
  start-page: e50412
  year: 2012
  ident: 217_CR9
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0050412
– volume: 150
  start-page: 5326
  year: 2009
  ident: 217_CR11
  publication-title: Endocrinology
  doi: 10.1210/en.2009-0528
– volume: 59
  start-page: 147
  year: 2015
  ident: 217_CR18
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201400173
– volume: 7
  start-page: e34289
  year: 2012
  ident: 217_CR35
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0034289
– volume: 103
  start-page: 66
  year: 2016
  ident: 217_CR17
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.115.117440
– volume: 3
  start-page: 105
  year: 2015
  ident: 217_CR37
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(14)70219-0
– volume: 39
  start-page: 2211
  year: 2016
  ident: 217_CR29
  publication-title: Diabetes Care
  doi: 10.2337/dc16-0499
– volume: 72
  start-page: 69
  year: 2013
  ident: 217_CR30
  publication-title: Pharmacological research
  doi: 10.1016/j.phrs.2013.03.011
– volume: 55
  start-page: 773
  issue: 3
  year: 2017
  ident: 217_CR36
  publication-title: Endocrine
  doi: 10.1007/s12020-016-1212-2
– volume: 1
  start-page: 97
  year: 2010
  ident: 217_CR21
  publication-title: Res Synth Methods
  doi: 10.1002/jrsm.12
– volume: 26
  start-page: 393
  issue: 5
  year: 2016
  ident: 217_CR23
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2016.03.003
– volume: 18
  start-page: 1167
  year: 2016
  ident: 217_CR1
  publication-title: Diabetes, obesity & metabolism
  doi: 10.1111/dom.12778
– volume: 32
  start-page: 537
  issue: 7
  year: 2012
  ident: 217_CR14
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2012.06.003
– volume: 93
  start-page: 522
  year: 2015
  ident: 217_CR25
  publication-title: Biochem Cell Biol
  doi: 10.1139/bcb-2014-0136
– volume: 59
  start-page: 554
  year: 2010
  ident: 217_CR12
  publication-title: Diabetes
  doi: 10.2337/db09-0482
– volume: 2016
  start-page: 9737483
  year: 2016
  ident: 217_CR6
  publication-title: J Diabetes Res
  doi: 10.1155/2016/9737483
– volume: 23
  start-page: 829
  year: 2012
  ident: 217_CR38
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2011.04.007
– volume: 114
  start-page: 796
  issue: 5
  year: 2015
  ident: 217_CR33
  publication-title: Br J Nutr
  doi: 10.1017/S0007114515002433
– volume: 59
  start-page: 1431
  year: 2015
  ident: 217_CR8
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.201400933
– volume: 10
  start-page: 2962
  year: 2011
  ident: 217_CR10
  publication-title: Genet Mol Res
  doi: 10.4238/2011.November.29.7
– volume: 99
  start-page: 1510
  year: 2014
  ident: 217_CR32
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.113.082024
– ident: 217_CR31
  doi: 10.1002/ptr.5737
– reference: 23918588 - Int J Sport Nutr Exerc Metab. 2014 Feb;24(1):2-13
– reference: 28050570 - J Diabetes Res. 2016;2016:9737483
– reference: 26234526 - Br J Nutr. 2015 Sep 14;114(5):796-803
– reference: 26305052 - Biochem Cell Biol. 2015 Oct;93(5):522-30
– reference: 19934007 - Diabetes. 2010 Mar;59(3):554-63
– reference: 27491724 - Diabetes Obes Metab. 2016 Dec;18(12 ):1157-1166
– reference: 20171754 - Diabetes Res Clin Pract. 2010 Mar;87(3):293-301
– reference: 24630390 - Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
– reference: 22479589 - PLoS One. 2012;7(3):e34289
– reference: 21852083 - J Nutr Biochem. 2012 Jul;23(7):829-37
– reference: 9310563 - BMJ. 1997 Sep 13;315(7109):629-34
– reference: 25137036 - Metab Syndr Relat Disord. 2014 Dec;12(10):497-501
– reference: 22901562 - Nutr Res. 2012 Jul;32(7):537-41
– reference: 23557933 - Pharmacol Res. 2013 Jun;72:69-82
– reference: 27550203 - Diabetes Obes Metab. 2016 Dec;18(12 ):1167-1175
– reference: 22180358 - Pharmacol Rep. 2011;63(5):1162-8
– reference: 17958896 - Nutr J. 2007 Oct 24;6:30
– reference: 19819963 - Endocrinology. 2009 Dec;150(12):5326-33
– reference: 18930334 - J Hepatol. 2008 Dec;49(6):1019-28
– reference: 25808216 - Mol Nutr Food Res. 2015 Aug;59(8):1431-42
– reference: 24701359 - ISRN Endocrinol. 2014 Feb 20;2014:816307
– reference: 27852684 - Diabetes Care. 2016 Dec;39(12 ):2211-2217
– reference: 25466521 - Lancet Diabetes Endocrinol. 2015 Feb;3(2):105-13
– reference: 24356595 - Diabetes Care. 2014;37(1):31-8
– reference: 24073011 - Evid Based Complement Alternat Med. 2013;2013:851267
– reference: 25138371 - Mol Nutr Food Res. 2015 Jan;59(1):147-59
– reference: 22179968 - Genet Mol Res. 2011 Nov 29;10(4):2962-75
– reference: 25577300 - Dig Liver Dis. 2015 Mar;47(3):226-32
– reference: 23226280 - PLoS One. 2012;7(11):e50412
– reference: 28070709 - Endocrine. 2017 Mar;55(3):773-785
– reference: 26061376 - Res Synth Methods. 2010 Apr;1(2):97-111
– reference: 26607942 - Am J Clin Nutr. 2016 Jan;103(1):66-70
– reference: 27105868 - Nutr Metab Cardiovasc Dis. 2016 May;26(5):393-9
– reference: 27520400 - Pharmacol Res. 2016 Sep;111:896-905
– reference: 24695890 - Am J Clin Nutr. 2014 Jun;99(6):1510-9
– reference: 26664429 - J Res Med Sci. 2015 Aug;20(8):797-810
– reference: 27807887 - Phytother Res. 2017 Jan;31(1):108-114
– reference: 21385509 - Br J Nutr. 2011 Aug;106(3):383-9
– reference: 20171303 - Int J Surg. 2010;8(5):336-41
SSID ssj0033490
Score 2.5017347
SecondaryResourceType review_article
Snippet Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes mellitus...
Abstract Although the regular consumption of resveratrol has been known to improve glucose homeostasis and reverse insulin resistance in type 2 diabetes...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 60
SubjectTerms Analysis
Bias
blood glucose
Blood pressure
Cholesterol
Clinical trials
computer software
Diabetes
Diabetes mellitus
diastolic blood pressure
Dosage and administration
Drug therapy
drugs
Fasting
Glucose
glycemic control
glycohemoglobin
Glycosylated hemoglobin
Hemoglobin
high density lipoprotein cholesterol
Homeostasis
Insulin
Insulin resistance
Kinases
Laboratory testing
low density lipoprotein cholesterol
Meta-analysis
noninsulin-dependent diabetes mellitus
patients
Quality control
randomized clinical trials
Resveratrol
Review
Statistical analysis
Supplements
Systematic review
systolic blood pressure
Type 2 diabetes
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQtDwCBRmEQEKKunHs2Oa2PKrCoQegUm-W7djQapugJotE_wB_m5nEWTZCwIVLpMSTaHdmPPONM_lMyNPgaiEhF-RcOA4H5nK7EDb3AuBzXReuHhtkj6ujE_7-VJxubfWFPWEjPfCouAMIDNoVkataVlwra5VQCxeDR6TBlcPoCzlvKqbGGFyWXE_vMAtVHXSQ1RRWzjJHDJ5fzbLQQNb_e0jeyknzfsmtBHR4k9xIyJEux198i1wLzS7ZWzZQNV98p8_o0Ms5LJLvkuzNWejhWmL9XNHjiXR_j_wYCYs72kYKtfY3ZFW-bFe0bWjqX6epf53apqapWZ122Ok-bjVB8XTtzoen4EIuxYVcyui0kPuS_iKIpuPHMcOzLkJvc5toUG6Tk8O3n14f5Wk7htxXTPY5j5HFABWPZUHb0hfaAhqoLBQssopOSecKG0IE7TPtFsp5ppyMQTpdC1Hp8g7Zadom3CO0YjZ6a30ppIPsKLTjokamehYBAS18RhaTeYxPXOW4ZcbKDDWLqsxoUQMWNWhRc5WRF5tbvo5EHX8TfoU23wgix_ZwATzPJM8z__K8jDxBjzHIotFgm85nu-468-7jB7NElA1IVsqMPE9CsYV_4G366gH0gMRbM8n9mSRMcz8fnhzTpDDTmUJzKDcBJfOMPN4M453YOteEdo0yA2ejZuLPMgxCsQbwqMuM3B19faMbfNGuuNIZkbNZMFPefKQ5-zIQlSM2L7W4_z-0_YBcZ8P81Tlj-2Snv1yHh4AHe_domPo_AeM2X9M
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggaHkECjIIgYRkddeJY5sLWh5V4dADUGlvlu04bdE2KZtdJPoH-NvMOM62EaKXlTaeRLsej-eb8eQbQl4GVwkJvoAVwhXwwR2zE2GZFwCfq2rqqr5A9rA8OCq-zMU8Jdy6VFY57Ilxo65ajznyPQi2AVkDICjenf9k2DUKT1dTC42b5BZSl-GqlvNNwJXnhR5OMqeq3OvAtymMnyVDJM4uRr4oUvb_uzFf8Uzjqskrbmj_LrmT8COd9Qq_R26EZpvszBqInc9-01c0VnTGVPk2yT6ehhVcS9yfC3o4UO_vkD89bXFH25pCxP0LuZWX7YK2DU1V7DRVsVPbVDSVrNMO6937hhMUv67dj_gUTOdSTOdSTod07lt6SRNN-1dk4rPOwsoym8hQ7pOj_U_fPxyw1JSB-ZLLFSvqmtcB4h7Lg7a5n2oLmKC0ELbIsnZKOje1IdQw-1y7iXKeKyfrIJ2uhCh1_oBsNW0THhFaclt7a30upAMfKbQrRIV89bwGHDTxGZkM6jE-MZZj44yFiZGLKk2vUQMaNahRc5GRN5tbznu6juuE36PON4LItB0vtMtjkwzXgGPSbloXqpJloZW1SqiJAw0h0i2Uy8gLXDEGuTQaLNY5tuuuM5-_fTUzxNqAZ6XMyOskVLfwD7xN7z7APCD91khydyQJxu7Hw8PCNGmz6cylaWTk-WYY78QCuia0a5SJzI2ai__LcNiQNUBInWfkYb_WN3ODx-2qUDojcmQFo8kbjzSnJ5GuHBF6rsXj63_6E3KbR8vUjPNdsrVarsNTwHsr9ywa9V9MvVbJ
  priority: 102
  providerName: ProQuest
Title Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/29018489
https://www.proquest.com/docview/1947530954
https://www.proquest.com/docview/1950181925
https://www.proquest.com/docview/2053907593
https://pubmed.ncbi.nlm.nih.gov/PMC5610395
https://doaj.org/article/eac9b1f48d76498aa8580bfec405748b
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1taxQxEA59-eIX0daX1XpEEQVh9S6bbBJB5Kot9cBDWg_6LST70lauu3ovYvsH_NvOZLNnF6v45Y7bzAYuk8k8k0yeIeRp4XIhwRfEXDgOH8zFti9snAmAz3k-cHmTIDtODyZ8dCyO10hb3ioM4Pza0A7rSU1m05c_vl28BYN_4w1epa_m4LMUxsUyRoQdX66TTXBMEgsafOSrQ4Uk4Trcj0xiCa4yHHJe20XHTXk2_z_X7CtOq5tQecVD7d8iNwO0pMNmLtwma0W1RbaHFYTV5xf0GfXJnn4XfYtE78-KBTwLtKBTOm5Z-bfJz4bReE7rkkIw_h1pl2f1lNYVDQnuNCS4U1vlNGSz0zmmwje1KCj-XLovvhfc6aW400sZbXd6X9PfDNK0uT3j-zovFja2gSflDpns731-dxCHeg1xljK5iHlZsrKAkMiyQtskG2gLcCG1ENHItHRKOjewRVGCJph2feUyppwsC-l0LkSqk7tko6qr4j6hKbNlZm2WCOnAfQrtuMiRyp6VAJH6WUT6rXpMFsjMsabG1PigRqWm0agBjRrUqLmMyIvVK18bJo9_Ce-izleCSMLtH9SzExNs2oDP0m5QcpXLlGtlrRKq70BDCIK5chF5gjPGIM1GhXk8J3Y5n5sPR4dmiDAcoK6UEXkehMoa_kFmw7UIGAdk5upI7nQkYR3Ius3txDStGZmB5hCPAozmEXm8asY3MbeuKuolynhSR83E32UYrNUaTEYnEbnXzPXV2OBJvOJKR0R2rKAzeN2W6uzUM5kjeE-0ePA_A_WQ3GDePnXM2A7ZWMyWxSMAhAvXI-vyWPbI5nA4OhrB9-7e-NNhz2-v9PwS8AtTgWLe
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqcoALgpafQAGD-JGQomadOLaREFoo1ZaWPUAr9ebaiVOKtknZ7ILaF-BteEZmEmfbCNFbL5EST6Jdjz3zjT3-hpDnzuZcgC8IE24TuDAbmoibMOMAn_N8YPM2QXacjvaST_t8f4n86c7CYFplZxMbQ51XGa6Rr0OwDcgaAEHy7uRHiFWjcHe1K6HRDottd_oLQrb67dYG6PcFY5sfdz-MQl9VIMxSJmZhUhSscADcDXPKxNlAGXBqqQHcLdLCSmHtwDhXRHHMlI2kzZi0onDCqpzzFMmXwORfA8cbYbAn9hcBXhwnqts5Hch0vQZfKjFeFyEi__Cs5_uaEgH_OoILnrCfpXnB7W3eIjc9XqXDdoDdJkuuXCGrwxJi9eNT-pI2GaTN0vwKCTaO3Ayeea7RCR13VP-r5HdLk1zTqqAQ4f9ELudpNaFVSX3WPPVZ89SUOfUp8rTG_Pq2wAXF27n93nwFl48pLh9TRrvl4zf0nJaatkdymm8du5kJjSdfuUP2rkRdd8lyWZXuPqEpM0VmTBZzYcEnc2UTniM_PisAd0VZQKJOPTrzDOlYqGOim0hJprrVqAaNatSoPgvI68UrJy09yGXC71HnC0Fk9m4eVNND7Q2FBkeo7KBIZC7SREljJJeRBQ0hsk6kDcgzHDEauTtKTA46NPO61ltfv-ghYnvAz0IE5JUXKir4B5nxZy2gH5Duqye51pME45L1m7uBqb1xq_X5VAzI00UzvokJe6Wr5ijTMEUqxv8vw8ABKICsKg7IvXasL_oGt_dlIlVARG8W9Dqv31IefWvo0TEiiBV_cPlPf0Kuj3Y_7-idrfH2Q3KDNbNUhYytkeXZdO4eAdac2cfNBKfk4Kotyl8Uq5Rc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+resveratrol+on+glucose+control+and+insulin+sensitivity+in+subjects+with+type+2+diabetes%3A+systematic+review+and+meta-analysis&rft.jtitle=Nutrition+%26+metabolism&rft.au=Zhu%2C+Xiangyun&rft.au=Wu%2C+Chunhua&rft.au=Qiu%2C+Shanhu&rft.au=Yuan%2C+Xuelu&rft.date=2017-09-22&rft.pub=BioMed+Central+Ltd&rft.issn=1743-7075&rft.eissn=1743-7075&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1186%2Fs12986-017-0217-z&rft.externalDBID=ISR&rft.externalDocID=A507111277
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-7075&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-7075&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-7075&client=summon